THE ROLE OF HEPATITIS-C VIRUS IN FULMINANT VIRAL-HEPATITIS IN AN AREA WITH ENDEMIC HEPATITIS-A AND HEPATITIS-B

被引:92
作者
CHU, CM [1 ]
SHEEN, IS [1 ]
LIAW, YF [1 ]
机构
[1] CHANG GUNG MED COLL, TAIPEI, TAIWAN
关键词
D O I
10.1016/0016-5085(94)90076-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: The role of hepatitis C virus in fulminant hepatitis remains controversial and needs further investigation. The aim of this study was to examine the role of hepatitis C virus in fulminant hepatitis in an area with endemic hepatitis A and B. Methods: Serological markers of hepatitis C virus were studied in 62 adults from Taiwan with fulminant viral hepatitis. Results: Of 62 patients, 5 (8.1%) were infected with acute type B hepatitis, 11 (17.7%) were infected with acute non-A, non-B hepatitis, and the remaining 46 (74.2%) were hepatitis B surface antigen (HBsAg) positive but immunoglobulin M (IgM) antibody to hepatitis B core antigen negative. Of the latter, 11 (23.9%) were IgM antibody to hepatitis D virus positive, 16 (34.8%) had high-titered serum hepatitis B virus DNA (>1000 pg/mL) and were suspected to have hepatitis B virus reactivation, and the other 19 (41.3%) had no identified causes. Serum hepatitis C virus RNA was found in 5 (45.5%) of 11 patients with fulminant non-A, non-B hepatitis, 3 (27.3%) of 11 HBsAg carriers with delta superinfection, and 6 (31.6%) of 19 HBsAg carriers with fulminant hepatitis of undetermined cause. Conclusions: Nearly half of fulminant non-A, non-B hepatitis and about 20% of HBsAg carriers with superimposed fulminant hepatitis in Taiwan could be attributed to hepatitis C virus infection. © 1994.
引用
收藏
页码:189 / 195
页数:7
相关论文
共 45 条
[1]  
ARANKALLE VA, 1988, LANCET, V1, P550
[2]   VIROLOGICAL MARKERS AND ANTIBODY-RESPONSES IN FULMINANT VIRAL-HEPATITIS [J].
BAL, V ;
AMIN, SN ;
RATH, S ;
KAMAT, SA ;
ZUCKERMAN, AJ ;
MARATHE, SN ;
KAMAT, RS .
JOURNAL OF MEDICAL VIROLOGY, 1987, 23 (01) :75-82
[3]   FULMINANT AND SUBFULMINANT LIVER-FAILURE - DEFINITIONS AND CAUSES [J].
BERNUAU, J ;
RUEFF, B ;
BENHAMOU, JP .
SEMINARS IN LIVER DISEASE, 1986, 6 (02) :97-106
[4]   WILD-TYPE AND E-ANTIGEN-MINUS HEPATITIS-B VIRUSES AND COURSE OF CHRONIC HEPATITIS [J].
BRUNETTO, MR ;
GIARIN, MM ;
OLIVERI, F ;
CHIABERGE, E ;
BALDI, M ;
ALFARANO, A ;
SERRA, A ;
SARACCO, G ;
VERME, G ;
WILL, H ;
BONINO, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (10) :4186-4190
[5]  
CARMAN WF, 1989, LANCET, V2, P588
[6]   ASSOCIATION OF A PRECORE GENOMIC VARIANT OF HEPATITIS-B VIRUS WITH FULMINANT-HEPATITIS [J].
CARMAN, WF ;
FAGAN, EA ;
HADZIYANNIS, S ;
KARAYIANNIS, P ;
TASSOPOULOS, NC ;
WILLIAMS, R ;
THOMAS, HC .
HEPATOLOGY, 1991, 14 (02) :219-222
[7]  
CHEN CY, 1993, CHIN J GASTROENTEROL, V10, P90
[8]   ISOLATION OF A CDNA CLONE DERIVED FROM A BLOOD-BORNE NON-A, NON-B VIRAL-HEPATITIS GENOME [J].
CHOO, QL ;
KUO, G ;
WEINER, AJ ;
OVERBY, LR ;
BRADLEY, DW ;
HOUGHTON, M .
SCIENCE, 1989, 244 (4902) :359-362
[9]   THE ETIOLOGY OF ACUTE HEPATITIS IN TAIWAN - ACUTE HEPATITIS SUPERIMPOSED ON HBSAG CARRIER STATE AS THE MAIN ETIOLOGY OF ACUTE HEPATITIS IN AREAS WITH HIGH HBSAG CARRIER RATE [J].
CHU, CM ;
SHEEN, IS ;
LIAW, YF .
INFECTION, 1988, 16 (04) :233-237
[10]   THE ETIOLOGY OF ACUTE HEPATITIS SUPERIMPOSED UPON PREVIOUSLY UNRECOGNIZED ASYMPTOMATIC HBSAG-CARRIERS [J].
CHU, CM ;
LIAW, YF ;
PAO, CC ;
HUANG, MJ .
HEPATOLOGY, 1989, 9 (03) :452-456